Literature DB >> 16362634

Neuropathological changes in ten cases of neuronal intermediate filament inclusion disease (NIFID): a study using alpha-internexin immunohistochemistry and principal components analysis (PCA).

R A Armstrong1, E Kerty, K Skullerud, N J Cairns.   

Abstract

Ten cases of neuronal intermediate filament inclusion disease (NIFID) were studied quantitatively. The alpha-internexin positive neurofilament inclusions (NI) were most abundant in the motor cortex and CA sectors of the hippocampus. The densities of the NI and the swollen achromatic neurons (SN) were similar in laminae II/III and V/VI but glial cell density was greater in V/VI. The density of the NI was positively correlated with the SN and the glial cells. Principal components analysis (PCA) suggested that PC1 was associated with variation in neuronal loss in the frontal/temporal lobes and PC2 with neuronal loss in the frontal lobe and NI density in the parahippocampal gyrus. The data suggest: 1) frontal and temporal lobe degeneration in NIFID is associated with the widespread formation of NI and SN, 2) NI and SN affect cortical laminae II/III and V/VI, 3) the NI and SN affect closely related neuronal populations, and 4) variations in neuronal loss and in the density of NI were the most important sources of pathological heterogeneity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16362634     DOI: 10.1007/s00702-005-0387-0

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  21 in total

1.  Cytoskeletal abnormalities in motor neuron disease. An immunocytochemical study.

Authors:  P N Leigh; A Dodson; M Swash; J P Brion; B H Anderton
Journal:  Brain       Date:  1989-04       Impact factor: 13.501

2.  Quantification of pathological lesions in the frontal and temporal lobe of ten patients diagnosed with Pick's disease.

Authors:  R A Armstrong; N J Cairns; P L Lantos
Journal:  Acta Neuropathol       Date:  1999-05       Impact factor: 17.088

3.  Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease.

Authors:  N J Cairns; M Grossman; S E Arnold; D J Burn; E Jaros; R H Perry; C Duyckaerts; B Stankoff; B Pillon; K Skullerud; F F Cruz-Sanchez; E H Bigio; I R A Mackenzie; M Gearing; J L Juncos; J D Glass; H Yokoo; Y Nakazato; S Mosaheb; J R Thorpe; K Uryu; V M-Y Lee; J Q Trojanowski
Journal:  Neurology       Date:  2004-10-26       Impact factor: 9.910

4.  Familial frontotemporal dementia with ubiquitin-positive, tau-negative inclusions.

Authors:  A Kertesz; T Kawarai; E Rogaeva; P St George-Hyslop; P Poorkaj; T D Bird; D G Munoz
Journal:  Neurology       Date:  2000-02-22       Impact factor: 9.910

5.  Patients with a novel neurofilamentopathy: dementia with neurofilament inclusions.

Authors:  Nigel J Cairns; Robert H Perry; Evelyn Jaros; David Burn; Ian G McKeith; James S Lowe; Janice Holton; Martin N Rossor; Kari Skullerud; Charles Duyckaerts; Felix F Cruz-Sanchez; Peter L Lantos
Journal:  Neurosci Lett       Date:  2003-05-08       Impact factor: 3.046

6.  Regional and cellular pathology in frontotemporal dementia: relationship to stage of disease in cases with and without Pick bodies.

Authors:  Cindy Kersaitis; Glenda M Halliday; Jillian J Kril
Journal:  Acta Neuropathol       Date:  2004-09-11       Impact factor: 17.088

7.  Frontal lobe dementia and motor neuron disease.

Authors:  D Neary; J S Snowden; D M Mann; B Northen; P J Goulding; N Macdermott
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-01       Impact factor: 10.154

8.  Achromatic neurons in the cortex of progressive supranuclear palsy.

Authors:  I R Mackenzie; L P Hudson
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

9.  alpha-internexin is present in the pathological inclusions of neuronal intermediate filament inclusion disease.

Authors:  Nigel J Cairns; Victoria Zhukareva; Kunihiro Uryu; Bin Zhang; Eileen Bigio; Ian R A Mackenzie; Marla Gearing; Charles Duyckaerts; Hideaki Yokoo; Yoichi Nakazato; Evelyn Jaros; Robert H Perry; Virginia M-Y Lee; John Q Trojanowski
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

10.  Neurofilament inclusion body disease: a new proteinopathy?

Authors:  Keith A Josephs; Janice L Holton; Martin N Rossor; Hans Braendgaard; Tetsutaro Ozawa; Nick C Fox; Ronald C Petersen; Gary S Pearl; Milan Ganguly; Pedro Rosa; Henning Laursen; Joseph E Parisi; Gunhild Waldemar; Niall P Quinn; Dennis W Dickson; Tamas Revesz
Journal:  Brain       Date:  2003-07-22       Impact factor: 13.501

View more
  4 in total

1.  Comparative quantitative study of 'signature' pathological lesions in the hippocampus and adjacent gyri of 12 neurodegenerative disorders.

Authors:  Richard A Armstrong; Nigel J Cairns
Journal:  J Neural Transm (Vienna)       Date:  2015-05-01       Impact factor: 3.575

2.  Spatial patterns of FUS-immunoreactive neuronal cytoplasmic inclusions (NCI) in neuronal intermediate filament inclusion disease (NIFID).

Authors:  Richard A Armstrong; Marla Gearing; Eileen H Bigio; Felix F Cruz-Sanchez; Charles Duyckaerts; Ian R A Mackenzie; Robert H Perry; Kari Skullerud; Hideaki Yokoo; Nigel J Cairns
Journal:  J Neural Transm (Vienna)       Date:  2011-07-27       Impact factor: 3.575

3.  The spectrum and severity of FUS-immunoreactive inclusions in the frontal and temporal lobes of ten cases of neuronal intermediate filament inclusion disease.

Authors:  Richard A Armstrong; Marla Gearing; Eileen H Bigio; Felix F Cruz-Sanchez; Charles Duyckaerts; Ian R A Mackenzie; Robert H Perry; Kari Skullerud; Hedeaki Yokoo; Nigel J Cairns
Journal:  Acta Neuropathol       Date:  2010-10-01       Impact factor: 17.088

4.  Different molecular pathologies result in similar spatial patterns of cellular inclusions in neurodegenerative disease: a comparative study of eight disorders.

Authors:  Richard A Armstrong; Nigel J Cairns
Journal:  J Neural Transm (Vienna)       Date:  2012-06-08       Impact factor: 3.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.